Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

publishing date : 2020 - 12 - 23    symbols : AZN    save search

Compugen Announces First Development Milestone in License Agreement with AstraZeneca for the Development of Bispecific and Multi-specific Antibody Products
Published: 2020-12-23 (Crawled : 18:00) - biospace.com/
CGEN | $2.03 3.57% 3.45% 450K twitter stocktwits trandingview |
Health Technology
| | O: 4.37% H: 0.88% C: -8.78%
AZN | $68.38 -0.22% 2.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.78% H: 0.02% C: -0.69%

license antibody milestone
Gainers vs Losers
72% 28%

Top 10 Gainers
AGBA | $1.05 162.5% 100M twitter stocktwits trandingview |
Finance

ISPC | $0.4621 116.95% 15M twitter stocktwits trandingview |
Professional, Scientific, and T...

INVO | $1.515 99.34% 4.3M twitter stocktwits trandingview |
Health Technology

BPTH | $5.62 73.46% 75M twitter stocktwits trandingview |
Health Technology

TIRX | $0.8231 69.78% 54M twitter stocktwits trandingview |

SINT | $0.0519 39.14% 350M twitter stocktwits trandingview |
Health Technology

XPON | $2.63 36.27% 8.4M twitter stocktwits trandingview |

VTNR S | $1.26 28.68% 9.1M twitter stocktwits trandingview |
Industrial Services

SWVL | $9.64 27.35% 200K twitter stocktwits trandingview |
n/a

DFLI A | $0.7726 25.52% 4.3M twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.